San Diego-based gene-sequencing giant Illumina got tangled in the United States’ trade tensions Tuesday as China placed the ...

Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results , but sales were flat year on year at $1.1 billion. On the ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

Illumina, Inc. engages in the development ... and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

China announced a wide range of measures on Tuesday targeting U.S. businesses including Google , farm equipment makers and ...

sees health care and pharmaceuticals as a key area for the expansion of his company’s AI products. Illumina shares gained 3.7% on Monday to $141.72. IQVIA, which is using Nvidia’s AI foundry ...

Patrick B Donnelly, an analyst from Citi, maintained the Hold rating on Illumina (ILMN – Research Report). The associated price target remains ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

It was put on a blacklist by the latter country. China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on ...